Rockwell Medical announced a product purchase agreement with an at-home and acute care dialysis provider in the United States. Under the terms of the agreement, Rockwell Medical will supply the Customer with the Company’s liquid acid RenalPure and liquid bicarbonate SteriLyte, both of which will be packaged in either the Company’s four-per-case packaging for larger dialysis settings or two-per-case packaging for smaller acute care and at-home care settings.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RMTI:
- Rockwell Medical signs distribution agreement with Nipro Medical
- Rockwell Med Unveils Updated Corporate Strategy Presentation
- Rockwell Medical raises 2024 revenue view to $90M-$94M from $95M-$98M
- Rockwell Medical reports Q2 EPS 5c vs. (12c) last year
- RMTI Earnings Report this Week: Is It a Buy, Ahead of Earnings?
